@nippy I agree generally with your point (long term performance) but the issue is in the following conundrum:
if you buy something at a discount, and sell it at a discount: what's the difference?
If you buy something at premium and sell it at a premium, what's the difference?
holders are forever buying at the discount and hoping the discount becomes a premium.
they literally got FDA approval and are starting to sell the product, AND the AA prospect for CHF is very real. Alas, despite the ASX climbing back over 8000, you would have paid a higher price to take a much higher risk (risking another CRL and sales hadn't even started) relative to today. We are forever buying at a discount.
What is going to trigger the discount to become a premium? It would seem that only approval on a blockbuster will do the trick at this point.
(20min delay)